Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial – CALGB/alliance 170601
- Citation:
- Eur J Cancer Care (Engl) vol 26 (2)
- Year:
- 2017
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 5
- Parents:
- None
- Children:
- None
- Program:
- CCP
- Primary Committee:
- Health Outcomes
- Sec. Committees:
- Onc Nursing
- Pharmas:
- Grants:
- P50 CA108961, U10 CA031946, P30 CA008748, U10 CA180850, UG1 CA189823
- Corr. Author:
- Authors:
- E.M.L. Smith H. Pang C. YE C. Cirrincione S. Fleishman E.D. Paskett T. Ahles L.R. Bressler N. Le-Lindqwister C.E. Fadul C. LoprinzI C.L. Shapiro
- Networks:
- HEARTLAND, LAPS-AL002, LAPS-MN026, LAPS-NC010, LAPS-NY016, LAPS-OH007, NY021, VA009
- Study
- CALGB-170601
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Duloxetine, chemotherapy-induced peripheral neuropathy, pain, oxaliplatin